Cargando…
New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells
In this paper, a novel series of imidazole-based heme oxygenase-1 (HO-1) inhibitors is reported. These compounds were obtained by modifications of previously described high potent and selective arylethanolimidazoles. In particular, simplification of the central linker and repositioning of the hydrop...
Autores principales: | Ciaffaglione, Valeria, Intagliata, Sebastiano, Pittalà, Valeria, Marrazzo, Agostino, Sorrenti, Valeria, Vanella, Luca, Rescifina, Antonio, Floresta, Giuseppe, Sultan, Ameera, Greish, Khaled, Salerno, Loredana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139504/ https://www.ncbi.nlm.nih.gov/pubmed/32168943 http://dx.doi.org/10.3390/ijms21061923 |
Ejemplares similares
-
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia
por: Ciaffaglione, Valeria, et al.
Publicado: (2022) -
Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation
por: Greish, Khaled F., et al.
Publicado: (2018) -
From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes
por: Floresta, Giuseppe, et al.
Publicado: (2021) -
Novel Heme Oxygenase-1 (HO-1) Inducers Based on Dimethyl Fumarate Structure
por: Sorrenti, Valeria, et al.
Publicado: (2020) -
Fourfold Filtered Statistical/Computational Approach for the Identification of Imidazole Compounds as HO-1 Inhibitors from Natural Products
por: Floresta, Giuseppe, et al.
Publicado: (2019)